NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
CC E-036-2009-0-IN-07 FEEDBACK SYSTEM FOR INTEGRATING INTERVENTIONAL PLANNING AND NAVIGATION IN National Stage 4497/CHENP/2011 Issued
CC E-036-2009-0-JP-06 A Feedback System For Integrating Interventional Planning And Navigation JP National Stage 2011-539118 Issued
CC E-036-2009-0-EP-04 A Feedback System For Integrating Interventional Planning And Navigation EP National Stage 09760315.3 Issued
CC E-036-2009-0-CN-05 A Feedback System For Integrating Interventional Planning And Navigation CN National Stage 200980148382.X Issued
NIAID E-317-2003-0-US-07 Accelerated Vaccination Strategies To Provide Protection Against Viral Infection US CON 12/613,018 8017130 Expired PDF
CC E-036-2009-0-PCT-02 A Feedback System For Integrating Interventional Planning And Navigation PCT PCT PCT/IB2009/054923 Expired
NIAID E-241-2001-0-US-10 Development of a Preventive Vaccine for Filovirus Infection in Primates US DIV 12/612,625 8124592 Expired PDF
NIAID E-241-2001-0-US-09 Development of a Preventive Vaccine for Filovirus Infection in Primates US DIV 12/612,621 8106027 Expired PDF
NIAID E-241-2001-0-US-08 Development of a Preventive Vaccine for Filovirus Infection in Primate US DIV 12/612,579 8106026 Expired PDF
NICHD E-153-2007-0-US-07 Nitroxide Radical As A Treatment For Neurodegeneration US National Stage 12/530,593 Abandoned
NCATS E-267-2008-0-PCT-02 Substituted Triazines And Purine Compounds, Methods Of Inhibiting Cruzain And Rhodesain And Methods Of Treating Chagas Disease And African Trypanosomiasis PCT PCT PCT/US2009/063078 Expired
NCI E-138-2001-0-US-04 Use of Semenogelin in the Diagonosis, Prognosis And Treatment of Cance US DIV 12/609,817 Abandoned
NHLBI E-142-2009-0-US-01 A Novel Strategy To Regulate Cholesterol Biosynthesis With MicroRNAs US 61/280,170 Abandoned
NINDS E-225-2009-0-US-01 COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF
MITOCHONDRIAL DISEASES 		US 61/256,601 Abandoned
NIDCR E-033-2004-0-CA-05 Multipotent Postnatal Stem Cells From Human Periodontal Ligament and Uses Thereof CA National Stage 2546760 Expired
CC E-285-2009-0-US-01 Cryopreservation And Storage Of Human Cellular Products Using Low Molecular Weight Pentastarch, Dimethylsulfoxide (DMSO) And Human Serum Albumin In Plasmalyte A Solution. US 61/256,075 Abandoned
NIAID E-305-2009-0-US-01 Antibody To Lutzomyia Longiapalpis Sand Fly Midgut Protein (LuloPer1): A Novel Leishmania Transmission Blocking Vaccine US 61/256,250 Abandoned
NCI E-138-2006-0-US-03 Highly Soluble Pyrimido-Dione-Quinoline Compounds and Their Use In The Treatment of Cancer US National Stage 12/304,980 8877765 Issued PDF
NCI E-132-2010-0-AU-01 Methods Of Diagnosing And Prognosing Colonic Polyps AU ORD 2009905277 Abandoned
NIDA E-052-2010-0-AU-01 Toll Like Receptor 4 (TLR4) Antagonists Modify The Action Of Alcohol AU ORD 2009905287 Abandoned
NIAID E-066-2003-5-US-04 Monoclonal Antibodies That Bind Or Neutralize Dengue Virus US DIV 12/607,035 8337853 Abandoned PDF
NIMH E-262-2009-0-US-01 2-Fluorothiazole derivatives Useful As Imaging Agents; Methods of Synthesis, And Methods of Use US ORD 12/605,467 Abandoned
NIDDK E-004-2010-0-US-01 Protection From Obesity And Diabetes By Blockade Of TGF-beta/Smad3 Signaling US 61/254,629 Abandoned
NEI E-198-2008-0-US-01 Systemic Immunosuppression in the Treatment of Age-Related Macular Degeneration and Diabetic Retinopathy US 61/254,439 Abandoned
NHGRI E-162-2001-0-US-03 Oligonucleotide-Tagged Semiconductor Nanocyrstrals for Microarray And Fluorescence In Situ Hybridizat US DIV 12/604,296 Abandoned
NCI E-303-2009-0-US-01 Methods, Compositions And Kits For MiRNA In Situ Hybridization Detection, Quantification And Identification Of Cancer Biomarkers And Companion Diagnostic Assay For Cancer Therapy US 61/253,617 Abandoned
NIAID E-301-2009-0-US-01 RSV Immunogens, Antibodies and Compositions Thereof US 61/253,826 Abandoned
NICHD E-040-2005-0-US-12 Methods For Preparing Immunogenic Conjugates US DIV 12/582,420 8481048 Abandoned PDF
NCI E-039-2003-0-US-03 COMBINATORIAL THERAPY FOR PROTEIN SIGNALING DISEASES US CON 12/581,019 8168568 Expired PDF
NICHD E-324-2008-0-PCT-02 Geminin Inhibitors as Tumor Treatment PCT PCT PCT/US2009/060949 Abandoned
NIAID E-300-2009-1-US-01 Neutralizing Antibodies Against HIV-1 And Their Use US 61/252,613 Abandoned
NIAID E-018-2010-0-US-01 Plasmid Shuttle Vector For Insertion Of Foreign Genes Into Del LIl Site Of Modi Fied Vaccinia Virus Ankara (MVA) To Increase Stability Of Foreign Gene Expression In This Site US 61/252,326 Abandoned
NIAID E-007-2010-0-US-01 Unique Method For Designing Expandable HIV Mosaic Vaccines To Allow For Improved Response To Newly Identified Epitopes US 61/252,545 Abandoned
NIDDK E-219-2011-2-PCT-01 CLINICAL DECISION MODEL PCT PCT COMB PCT/US2009/060850 Abandoned
NCI E-339-2002-0-US-04 Method and Apparatus for Performing Multiple Simultaneous Manipulations of Biomolecules In A Two-Dimensional Array US CON 12/587,976 8283158 Abandoned PDF
NIMH E-274-2015-0-US-01 DT390-EGF Fusion Protein For Treatment Of EGF Receptor Positive Cancers US 61/251,676 Abandoned
NIAID E-010-2011-0-US-01 Recombinant MVA Viruses Expressing Clades A/G, B, And C Modified HIV env, Gag And Pol Genes; Recombinant MVA Expressing GM-CSF. US 61/251,119 Abandoned
NCI E-065-2005-1-US-02 NOVOBIOCIN ANALOGUES AS NEUROPROTECTIVE AGENTS AND IN THE TREATMENT OF AUTOIMMUNE DISORDERS US CON 12/577,620 7960353 Expired PDF
NCI E-158-2009-0-US-01 Granulysin Immunotherapy US 61/250,601 Abandoned
NCI E-322-2008-0-PCT-02 METHOD OF MAKING A VACCINE PCT PCT PCT/US2009/060303 Expired
NCI E-322-2008-0-EP-04 Method of Making A Vaccine EP National Stage 09820027.2 Abandoned
NCATS E-326-2008-0-CA-19 BIS SULFONAMIDE PIPERAZINYL AND PIPERIDINYL ACTIVATORS OF HUMAN PYRUVATEKINASE CA DIV 3041868 Issued
NCATS E-326-2008-0-EP-13 Activators Of Human Pyruvate Kinase EP DIV 16207004.9 Issued
NCATS E-326-2008-0-EP-05 Activators Of Human Pyruvate Kinase EP National Stage 09740795.1 Issued
NCATS E-326-2008-0-IT-18 Activators Of Human Pyruvate Kinase IT EP 09740795.1 Issued
NCATS E-326-2008-0-FR-16 Activators Of Human Pyruvate Kinase FR EP 09740795.1 Issued
NCATS E-326-2008-0-DE-14 Activators Of Human Pyruvate Kinase DE EP 09740795.1 Issued
NCATS E-326-2008-0-GB-17 Activators Of Human Pyruvate Kinase GB EP 09740795.1 Issued
NCATS E-326-2008-0-ES-15 Activators Of Human Pyruvate Kinase ES EP 09740795.1 Issued
NCATS E-326-2008-0-AU-03 Activators Of Human Pyruvate Kinase AU National Stage 2009303335 Issued